BioCrude Technologies USA, Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/41b56624-8dd8-4f4f-9130-47c08ae86cd2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-194.0k | 2025-01-01 – 2025-12-31 | evidence 0001731122-26-000496 |
| FY 2024 | $-277.1k | 2024-01-01 – 2024-12-31 | evidence 0001731122-25-000459 |
| FY 2023 | $-240.4k | 2023-01-01 – 2023-12-31 | evidence 0001731122-24-000503 |
| FY 2022 | $-177.7k | 2022-01-01 – 2022-12-31 | evidence 0001731122-23-000488 |
| FY 2021 | $-427.3k | 2021-01-01 – 2021-12-31 | evidence 0001731122-22-000498 |
| FY 2020 | $-283.7k | 2020-01-01 – 2020-12-31 | evidence 0001731122-21-000226 |
| FY 2019 | $-274.3k | 2019-01-01 – 2019-12-31 | evidence 0001731122-20-000283 |
| FY 2018 | $-808.5k | 2018-01-01 – 2018-12-31 | evidence 0001731122-19-000199 |
| FY 2017 | $-497.9k | 2017-01-01 – 2017-12-31 | evidence 0001731122-19-000199 |
| FY 2016 | $-184.0k | 2016-01-01 – 2016-12-31 | evidence 0001615774-18-002109 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).